Diebold Nixdorf, Incorporated
corporate_fare Company Profile
Diebold Nixdorf, Incorporated (NYSE:DBD) is a publicly traded company in the Technology sector. Wiseek has independently scored 16 items for DBD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 8/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for DBD spans 10-Q, 8-K, SCHEDULE 13D/A, 4.
Recent high-impact activity:
- Diebold Nixdorf Q3 EPS Falls to $0.19 as Charges Bite; New $250M Buyback Authorized
- Diebold Nixdorf Cuts 2026 Outlook Despite 5% Q3 Revenue Growth; Authorizes New $250M Buyback
- Diebold Nixdorf Posts 19c Q3 EPS but Slashes Full-Year EBITDA and Cash Flow Outlook
- Judge Threatens Sanctions Over Undisclosed Romance in Diebold Bankruptcy
- Capital World Investors' Diebold Nixdorf Stake Climbs to 34.9% as Share Count Contracts
Financial Snapshot
Short Interest & Short Volume
7.96 days to coverFINRA reported short interest of 3,180,656 shares in DBD as of the October 30, 2026 settlement, a 3.4% increase from the prior period — about 8.0 days to cover at its recent average daily volume. On November 20, 2026, 77.1% of DBD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.